CN103520183A - Phyllanthoid A在制备降低血糖药物中的应用 - Google Patents
Phyllanthoid A在制备降低血糖药物中的应用 Download PDFInfo
- Publication number
- CN103520183A CN103520183A CN201310499648.3A CN201310499648A CN103520183A CN 103520183 A CN103520183 A CN 103520183A CN 201310499648 A CN201310499648 A CN 201310499648A CN 103520183 A CN103520183 A CN 103520183A
- Authority
- CN
- China
- Prior art keywords
- phyllanthoid
- group
- application
- blood glucose
- blood sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- PRYDWZYABKDNOC-UHZUCAEESA-N phyllanthoid A Natural products CC(=O)O[C@@H]1[C@@H](O)[C@@]23[C@@H]4OC[C@@]5([C@H](O)C[C@H]2[C@@](C)([C@H](O)O4)[C@@H]1OC(=O)C)[C@@H]3[C@@H](O)[C@@H]6[C@@](C)(O)[C@@](O)(C[C@H]7O[C@@]567)c8cocc8 PRYDWZYABKDNOC-UHZUCAEESA-N 0.000 title claims abstract description 30
- 239000003814 drug Substances 0.000 title claims abstract description 15
- 239000008280 blood Substances 0.000 title claims description 28
- 210000004369 blood Anatomy 0.000 title claims description 28
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 19
- 239000008103 glucose Substances 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 11
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 8
- 230000003178 anti-diabetic effect Effects 0.000 abstract description 6
- 239000003472 antidiabetic agent Substances 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 description 8
- 241000700159 Rattus Species 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000011552 rat model Methods 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241001179670 Phyllanthus cochinchinensis Species 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 150000002630 limonoids Chemical class 0.000 description 3
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 3
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- BOVGTQGAOIONJV-BETUJISGSA-N 1-[(3ar,6as)-3,3a,4,5,6,6a-hexahydro-1h-cyclopenta[c]pyrrol-2-yl]-3-(4-methylphenyl)sulfonylurea Chemical group C1=CC(C)=CC=C1S(=O)(=O)NC(=O)NN1C[C@H]2CCC[C@H]2C1 BOVGTQGAOIONJV-BETUJISGSA-N 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 238000013295 T2DM animal model Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
组别 | 动物数(只) | 给药量(mg/kgBW) |
正常对照组 | 12 | |
模型对照组 | 12 |
阳性药物组 | 12 | 35.5 |
低剂量组 | 12 | 0.2 |
中剂量组 | 12 | 0.4 |
高剂量组 | 12 | 0.8 |
组别 | 动物数(只) | 给药前血糖值 | 给药后血糖值 |
正常对照组 | 10 | 5.93±0.43 | 5.68±1.16 |
模型对照组 | 9 | 13.57±2.37 | 34.62±2.37 |
阳性药物组 | 9 | 31.27±2.74 | 18.27±2.34**△△ |
低剂量组 | 8 | 31.17±2.37 | 24.53±2.28**△△ |
中剂量组 | 10 | 33.22±1.69 | 19.28±2.45**△△ |
高剂量组 | 9 | 37.22±2.57 | 18.42±3.41**△△ |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310499648.3A CN103520183B (zh) | 2013-10-22 | 2013-10-22 | Phyllanthoid A在制备降低血糖药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310499648.3A CN103520183B (zh) | 2013-10-22 | 2013-10-22 | Phyllanthoid A在制备降低血糖药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103520183A true CN103520183A (zh) | 2014-01-22 |
CN103520183B CN103520183B (zh) | 2016-03-09 |
Family
ID=49922772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310499648.3A Active CN103520183B (zh) | 2013-10-22 | 2013-10-22 | Phyllanthoid A在制备降低血糖药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103520183B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107814823A (zh) * | 2017-11-15 | 2018-03-20 | 南京正亮医药科技有限公司 | 一种治疗糖尿病的化合物及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1922200A (zh) * | 2003-12-31 | 2007-02-28 | 拉帕波特家族医学研究院 | 预测抗氧化剂治疗在预防高血糖患者的心血管疾病中的益处的方法 |
-
2013
- 2013-10-22 CN CN201310499648.3A patent/CN103520183B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1922200A (zh) * | 2003-12-31 | 2007-02-28 | 拉帕波特家族医学研究院 | 预测抗氧化剂治疗在预防高血糖患者的心血管疾病中的益处的方法 |
Non-Patent Citations (2)
Title |
---|
JIAN-QIANG ZHAO,ET AL: "Two New Highly Oxygenated and Rearranged Limonoids from Phyllanthus cochinchinensis", 《ORGANIC LETTERS》 * |
黎继烈: "金橘活性物质提取及生物活性研究", 《中国博士学位论文全文数据库》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107814823A (zh) * | 2017-11-15 | 2018-03-20 | 南京正亮医药科技有限公司 | 一种治疗糖尿病的化合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103520183B (zh) | 2016-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3403664A1 (en) | Use ofcistanche tubulosa | |
CN103520183B (zh) | Phyllanthoid A在制备降低血糖药物中的应用 | |
CN102895226B (zh) | Aphanamixoid A在制备降低血糖药物中的应用 | |
CN103479625B (zh) | Fluevirosines A在制备降低血糖药物中的应用 | |
CN103251616A (zh) | Aspeverin在制备降低血糖药物中的应用 | |
CN103463100A (zh) | Kadcoccitones A在制备降低血糖药物中的应用 | |
CN102872045B (zh) | Gypensapogenin A在制备降低血糖药物中的应用 | |
CN105168226A (zh) | 一种降低血糖的药物及其应用 | |
CN106265650A (zh) | Ternatusine A在制备降低血糖药物中的应用 | |
CN103638006B (zh) | Oleaceran在降低血糖药物中的应用 | |
CN102988386B (zh) | Houttuynoid E在制备降低血糖药物中的应用 | |
CN103285008A (zh) | Myriberine A在制备降低血糖药物中的应用 | |
CN105250324A (zh) | Commersonine在制备降低血糖药物中的应用 | |
CN105343057A (zh) | Aogacillin B在制备降低血糖药物中的应用 | |
CN101502529B (zh) | 白前苷b在制备抗糖尿病药物中的应用 | |
CN105902527A (zh) | 一种具有降低血糖作用的药物组合物及其制备方法和应用 | |
CN103356592B (zh) | Chukrasone B在制备降低血糖药物中的应用 | |
CN103462986A (zh) | Spirooliganones B在制备降低血糖药物中的应用 | |
CN105434420A (zh) | Tylopilusin C在制备降低血糖药物中的应用 | |
CN105456251A (zh) | Rhodomicranols B在制备降低血糖药物中的应用 | |
Fasola et al. | Screening for the Hypoglycaemic Potentials of the Extract of Vernonia amyggalina | |
CN106389443A (zh) | Friedolanostanes在制备降低血糖药物中的应用 | |
CN105250263A (zh) | Foveolide B在制备降低血糖药物中的应用 | |
CN103393662A (zh) | Sarcaboside B在制备降低血糖药物中的应用 | |
CN103393642A (zh) | Sarcaboside A在降低血糖药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Pang Yuelin Inventor after: Li Peigang Inventor after: Zhang Fan Inventor after: Wang Chunyan Inventor after: He Chuan Inventor before: The inventor has waived the right to be mentioned |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160215 Address after: 550018 Guizhou Province, Guiyang city Wudang District High Road No. 25 Applicant after: Xi'an Tian An Pharmaceutical Shares Co., Ltd. Address before: 211200, No. 1, industrial town, crystal Town, Lishui District, Jiangsu, Nanjing Applicant before: Sun Aihua |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |